Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: EFFORT Further Extension Study [Phase 4]
Phase 4 extension study update for chronic hepatitis B (EFFORT Further Extension Study); current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults [Phase 4]
A Phase 4 clinical trial evaluating pegylated interferon alfa-2a (Pegasys) in Korean adults with chronic hepatitis B; the current status of …
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients [Phase 2]
A Phase 2 study evaluating GC1102, a recombinant hepatitis B immunoglobulin, in hepatitis B-related liver transplant recipients has complete…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
A Stanford-led clinical trial investigating viral and host factors associated with HBV-related hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam
Observational study of Pegasys (peginterferon alfa-2a) in HBeAg-positive chronic hepatitis B patients in Vietnam; study terminated with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of CKD-390 Tablet for chronic hepatitis B, with current status not provided.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates [Phase 4]
This Phase 4 clinical trial evaluates safety and immunogenicity of recombinant hepatitis B vaccines in neonates. The current status of the t…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B
A completed clinical trial evaluated ShearWave Elastography as a noninvasive tool to assess liver fibrosis in Chinese patients with Hepatiti…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Retrovirus Epidemiology Donor Study-II (REDS-II)
Clinical trial update for the REDS-II study conducted by NHLBI; the trial is completed and investigates retroviral infections in blood donor…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB). [Phase 2]
This is a Phase 2 clinical trial evaluating intermittent long-term treatment with Pegasys (peginterferon alfa-2a, 40 kDa) in patients with H…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
An observational cohort study evaluated outcomes in patients with chronic hepatitis B treated with Pegasys (pegylated interferon alfa-2a); t…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue
This clinical trial update notes that a study collecting blood biomarker samples from participants with chronic hepatitis B who were treated…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of E/C/F/TAF (Genvoya) in adults co-infected with HIV-1 and hepatitis B virus.
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer [NA]
This clinical trial update discusses the efficacy and significance of antiviral therapy for unresectable hepatocellular carcinoma related to…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients [Phase 4]
A Phase 4 trial evaluating switching to Tenofovir disoproxil fumarate versus continuing Lamivudine/Adefovir in lamivudine-resistant chronic …
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B [NA]
A completed trial compared the efficacy of combining Tenofovir with Telbivudine versus Tenofovir alone in patients with spontaneous reactiva…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients
This clinical trial update presents long-term results on the anti-HBV effects of tenofovir and resistance surveillance in Asian-American adu…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B [Phase 4]
Phase 4 follow-up study assessing long-term post-treatment effects of PEGASYS (peginterferon alfa-2a) in patients with HBeAg-positive chroni…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA [NA]
A prospective study evaluating the specificity of Roche's Cobas TaqScreen MPX test for detecting HBV DNA, HCV RNA, and HIV-1 RNA in plasma p…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder [Phase 4]
Phase 4 trial evaluating long-term persistence of immunity to Hepatitis B in adolescents previously vaccinated in infancy with Engerix-B.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Study of Telbivudine in Chronic Hepatitis B
Clinical trial studying telbivudine for chronic hepatitis B has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus
A completed clinical trial evaluating early screening tools to monitor renal proximal tubular tolerance of nucleoside and nucleotide analogu…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection [Phase 2]
Phase 2 clinical trial assessing the efficacy of tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive patients co-infecte…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B [Phase 4]
Phase 4 study evaluating combination or sequential therapy with PEGASYS (peginterferon alfa-2a) and entecavir in HBeAg-positive chronic hepa…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B [Phase 1]
A Phase I safety and tolerability study of birinapant in chronic hepatitis B was terminated.